Vir Biotechnology, Inc. (VIR) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $1.00B | -28.3% |
| 2024 | $1.40B | -27.1% |
| 2023 | $1.92B | -31.5% |
| 2022 | $2.80B | +43.4% |
| 2021 | $1.95B | +112.7% |
| 2020 | $918.76M | +79.4% |
| 2019 | $512.07M | +167.3% |
| 2018 | $191.60M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $1.00B | -28.3% |
| 2024 | $1.40B | -27.1% |
| 2023 | $1.92B | -31.5% |
| 2022 | $2.80B | +43.4% |
| 2021 | $1.95B | +112.7% |
| 2020 | $918.76M | +79.4% |
| 2019 | $512.07M | +167.3% |
| 2018 | $191.60M | — |